Safety of lorlatinib following alectinib-induced pneumonitis in two patients with <i>ALK</i>-rearranged non-small cell lung cancer: a case series.

Transl Lung Cancer Res · 2021 · PMC7867755 · PMID 33569330

Europe PMC DOI

hedged sentence

0.0920

closest p · 1.8× alpha

0.0920

boldest claim

The sentences

did not reach statistical significanceP=0.092so close (0.05 < p ≤ 0.1)

2.68%) did not reach statistical significance (P=0.092) ( 13 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.